Services · Drug development
Biostatistics for drug development.
Analysis of clinical trial data, drug efficacy, and safety, built to meet the requirements your submission will be judged against.
What is involved
Moving a compound toward approval means every efficacy claim and safety profile must survive statistical scrutiny. We analyse trial data, conduct efficacy studies, and assess safety so the evidence holds together as a submission.
The work spans survival analysis, mixed models, and the advanced modeling a regulator expects to see applied correctly and documented fully.
Who this is for
Pharmaceutical companies, biotech firms, and researchers involved in drug development who need reliable biostatistical support behind their studies.
Why teams choose ASC for this work
- Biostatistical expertise built across pharmaceutical projects
- Regulatory compliance understood at every stage of development
- Rigorous analysis: the modeling matched to the data, not the other way round
- A collaborative working style with transparent communication
- Delivery that respects development timelines
Preparing evidence for a submission?
Bring us the programme and the questions it must answer. We will show you the statistical route.